ReviewCurrent oncology reports2022

Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction.

Irma Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.